Liquidia Technologies (NASDAQ:LQDA) Trading 10.1% Higher - What's Next?

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report)'s share price rose 10.1% during trading on Tuesday . The stock traded as high as $16.62 and last traded at $16.63. Approximately 2,478,247 shares were traded during mid-day trading, an increase of 61% from the average daily volume of 1,534,994 shares. The stock had previously closed at $15.10.

Analyst Ratings Changes

Several research firms have recently weighed in on LQDA. Wall Street Zen raised shares of Liquidia Technologies from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd. BTIG Research reaffirmed a "buy" rating on shares of Liquidia Technologies in a research report on Tuesday, May 27th. Wells Fargo & Company increased their price target on Liquidia Technologies from $23.00 to $25.00 and gave the stock an "overweight" rating in a research report on Thursday, June 12th. Raymond James Financial lifted their price objective on Liquidia Technologies from $27.00 to $29.00 and gave the company a "strong-buy" rating in a report on Friday, May 9th. Finally, Oppenheimer set a $13.00 price target on Liquidia Technologies and gave the company an "underperform" rating in a report on Monday, May 19th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, six have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, Liquidia Technologies currently has an average rating of "Moderate Buy" and a consensus target price of $26.89.

Liquidia Technologies Stock Performance

The firm's fifty day moving average is $14.85 and its 200-day moving average is $14.70. The company has a current ratio of 2.93, a quick ratio of 2.91 and a debt-to-equity ratio of 2.08. The stock has a market capitalization of $1.68 billion, a PE ratio of -12.40 and a beta of -0.01.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). Liquidia Technologies had a negative return on equity of 177.91% and a negative net margin of 903.80%. The company had revenue of $3.12 million for the quarter, compared to analysts' expectations of $3.23 million. As a group, research analysts anticipate that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current year.

Insider Activity at Liquidia Technologies

In other news, insider Scott Moomaw sold 4,797 shares of the business's stock in a transaction dated Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $68,501.16. Following the completion of the transaction, the insider directly owned 223,231 shares of the company's stock, valued at approximately $3,187,738.68. The trade was a 2.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, General Counsel Russell Schundler sold 7,836 shares of Liquidia Technologies stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $111,898.08. Following the completion of the transaction, the general counsel owned 577,977 shares of the company's stock, valued at $8,253,511.56. This represents a 1.34% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 59,215 shares of company stock worth $846,229 over the last ninety days. Company insiders own 26.50% of the company's stock.

Institutional Trading of Liquidia Technologies

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Cetera Investment Advisers lifted its stake in Liquidia Technologies by 4.3% during the fourth quarter. Cetera Investment Advisers now owns 31,243 shares of the company's stock worth $367,000 after purchasing an additional 1,277 shares during the last quarter. Deutsche Bank AG raised its stake in Liquidia Technologies by 53.4% during the 4th quarter. Deutsche Bank AG now owns 51,075 shares of the company's stock worth $601,000 after acquiring an additional 17,790 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Liquidia Technologies during the fourth quarter worth about $218,000. Millennium Management LLC acquired a new stake in shares of Liquidia Technologies during the fourth quarter worth about $526,000. Finally, GAMMA Investing LLC lifted its holdings in shares of Liquidia Technologies by 2,342.7% in the 1st quarter. GAMMA Investing LLC now owns 43,675 shares of the company's stock valued at $644,000 after purchasing an additional 41,887 shares during the last quarter. 64.54% of the stock is currently owned by institutional investors and hedge funds.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).